Display Settings:

Format

Send to:

Choose Destination
    PLoS Genet. 2010 Dec 23;6(12):e1001257.

    Cancer and neurodegeneration: between the devil and the deep blue sea.

    Source

    Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom. h.plun-favreau@ion.ucl.ac.uk

    Abstract

    Cancer and neurodegeneration are often thought of as disease mechanisms at opposite ends of a spectrum; one due to enhanced resistance to cell death and the other due to premature cell death. There is now accumulating evidence to link these two disparate processes. An increasing number of genetic studies add weight to epidemiological evidence suggesting that sufferers of a neurodegenerative disorder have a reduced incidence for most cancers, but an increased risk for other cancers. Many of the genes associated with either cancer and/or neurodegeneration play a central role in cell cycle control, DNA repair, and kinase signalling. However, the links between these two families of diseases remain to be proven. In this review, we discuss recent and sometimes as yet incomplete genetic discoveries that highlight the overlap of molecular pathways implicated in cancer and neurodegeneration.

    PMID:
    21203498
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3009676
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Figure 1

      Supplemental Content

      Icon for Public Library of Science Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk